Cyclic adenosine 3':5'-monophosphate phosphodiesterase activity in malignant and cyclic adenosine 3':5'-monophosphate-induced "differentiated" neuroblastoma cells
- PMID: 234030
Cyclic adenosine 3':5'-monophosphate phosphodiesterase activity in malignant and cyclic adenosine 3':5'-monophosphate-induced "differentiated" neuroblastoma cells
Abstract
The regulation of cyclic adenosine 3:5-monophosphate (cyclic AMP) phosphodiesterase activity in homogenates of malignant and cyclic AMP-induced "differentiated" neuroblastoma cells was studied. Neuroblastoma cells of at least three mouse and one human clone had both the low (2 to 4 muM) and the high (66 to 106 muM) Km phosphodiesterase. In cyclic AMP-induced differentiated cells the values of Km were decreased, whereas the values of Vmax appeared to be slightly increased. Magnesium and manganese stimulated phosphodiesterase activity. Calcium, zinc, copper, mercury, ethylenediaminetetraacetic acid, and imidazole completely inhibited phosphodiesterase activity in malignant cells, whereas the above agents, except ethylenediaminetetraacetic acid, only partially inhibited enzyme activity in differentiated cells. Ethylenediaminetetraacetic acid completely reduced phosphodiesterase activity in differentiated cells. The pH optimum for phosphodiesterase activity was about 8 in both malignant and differentiated cells. The present studies show that the values of Km and Vmax and the sensitivity of phosphodiesterase activity to divalent ions change in cyclic AMP-induced differentiated neuroblastoma cells, and therefore we propose that the reverse may be true during malignant transformation of nerve cells.
Similar articles
-
Effect of neurotransmitters, Guanosine triphosphate, and divalent ions on the regulation of adenylate cyclase activity in malignant and adenosine cyclic 3':5'-monophosphate-induced "differentiated" neuroblastoma cells.Cancer Res. 1975 Jan;35(1):77-81. Cancer Res. 1975. PMID: 162867
-
Binding of cyclic nucleotides with proteins in malignant and adenosine cyclic 3':5'-monophosphate-induced "differentiated" neuroblastoma cells in culture.Cancer Res. 1976 Jul;36(7 PT 1):2290-6. Cancer Res. 1976. PMID: 179701
-
Increased activity of low-Km cyclic adenosine 3':5'-monophosphate phosphodiesterase in plasma membranes of Morris hepatoma 5123tc (h).Cancer Res. 1975 Mar;35(3):601-5. Cancer Res. 1975. PMID: 163686
-
Differential activation and inhibition of the multiple forms of cyclic nucleotide phosphodiesterase.Adv Cyclic Nucleotide Res. 1975;5:195-211. Adv Cyclic Nucleotide Res. 1975. PMID: 165666 Review.
-
Cyclic nucleotides in the regulation of expression of differentiated functions in neuroblastoma cells.J Natl Cancer Inst. 1976 Sep;57(3):619-31. doi: 10.1093/jnci/57.3.619. J Natl Cancer Inst. 1976. PMID: 10449 Review.
Cited by
-
Novel protein inhibitor of calmodulin-dependent cyclic nucleotide phosphodiesterase from glioblastoma multiforme.Neurochem Res. 1998 Apr;23(4):533-8. doi: 10.1023/a:1022434602362. Neurochem Res. 1998. PMID: 9566588
-
A further study on the regulation of cyclic nucleotide phosphodiesterase activity in neuroblastoma cells: effect of growth.In Vitro. 1977 Aug;13(8):497-501. doi: 10.1007/BF02615142. In Vitro. 1977. PMID: 198356
-
A comparison of cAMP phosphodiesterases in normal, malignant, and somatic cell hybrids.Biochem Genet. 1977 Oct;15(9-10):1001-4. doi: 10.1007/BF00483994. Biochem Genet. 1977. PMID: 201244